Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO9650 | Zanthoxylum nitidum | Species | Rutaceae | Eukaryota | TM-MC* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT517 | Cell Line | Panel NCI-60 (60 carcinoma cell lines) | Homo sapiens | GI50 | = | 125 | nM | 15743190 |
NPT485 | Organism | Plasmodium falciparum (isolate K1 / Thailand) | Plasmodium falciparum K1 | IC50 | = | 400 | nM | 15808457 |
NPT26 | Individual Protein | Reverse transcriptase | Human immunodeficiency virus 1 | IC50 | < | 50 | ug/ml | 1710653 |
NPT26 | Individual Protein | Reverse transcriptase | Human immunodeficiency virus 1 | IC50 | = | 49 | ug/ml | 1710653 |
NPT24 | Organism | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | EC50 | = | 14000 | nM | 11430019 |
NPT729 | Organism | Micrococcus luteus | Micrococcus luteus | Activity | = | 5000 | ug/ml | 15270571 |
NPT729 | Organism | Micrococcus luteus | Micrococcus luteus | IC50 | = | 200 | ug/ml | 15270571 |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | Activity | = | 5000 | ug/ml | 15270571 |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | IC50 | = | 300 | ug/ml | 15270571 |
NPT602 | Organism | Mycobacterium smegmatis | Mycobacterium smegmatis | Activity | > | 5000 | ug/ml | 15270571 |
NPT602 | Organism | Mycobacterium smegmatis | Mycobacterium smegmatis | IC50 | = | 1000 | ug/ml | 15270571 |
NPT1513 | Organism | Mycobacterium avium | Mycobacterium avium | Activity | > | 5000 | ug/ml | 15270571 |
NPT1513 | Organism | Mycobacterium avium | Mycobacterium avium | IC50 | = | 3000 | ug/ml | 15270571 |
NPT20 | Organism | Candida albicans | Candida albicans | Activity | = | 200 | ug/ml | 15270571 |
NPT20 | Organism | Candida albicans | Candida albicans | Activity | = | 20 | ug/ml | 15270571 |
NPT85 | Organism | Filobasidiella neoformans | Cryptococcus neoformans | Activity | = | 300 | ug/ml | 15270571 |
NPT85 | Organism | Filobasidiella neoformans | Cryptococcus neoformans | Activity | = | 80 | ug/ml | 15270571 |
NPT312 | Organism | Saccharomyces cerevisiae | Saccharomyces cerevisiae | Activity | = | 3000 | ug/ml | 15270571 |
NPT312 | Organism | Saccharomyces cerevisiae | Saccharomyces cerevisiae | IC50 | = | 300 | ug/ml | 15270571 |
NPT21 | Organism | Aspergillus niger | Aspergillus niger | Activity | > | 5000 | ug/ml | 15270571 |
NPT21 | Organism | Aspergillus niger | Aspergillus niger | IC50 | = | 3000 | ug/ml | 15270571 |
NPT2 | Others | Unspecified | Activity | = | 116 | % | 2413172 | |
NPT2 | Others | Unspecified | Activity | = | 1 | % | 2413172 | |
NPT2 | Others | Unspecified | Activity | = | 11 | % | 2413172 | |
NPT2 | Others | Unspecified | Activity | = | 102 | % | 2413172 | |
NPT2 | Others | Unspecified | Activity | = | 85 | % | 2413172 | |
NPT2 | Others | Unspecified | Activity | = | 88 | % | 2413172 | |
NPT2 | Others | Unspecified | Activity | = | 5 | % | 2413172 | |
NPT2 | Others | Unspecified | Activity | = | 2 | % | 2413172 | |
NPT91 | Cell Line | KB | Homo sapiens | ED50 | = | 4.3 | ug/ml | 7130986 |
NPT2 | Others | Unspecified | Inhibition | = | 50 | % | 88001 | |
NPT165 | Cell Line | HeLa | Homo sapiens | IC50 | = | 0.05 | ug/ml | 10395504 |
NPT139 | Cell Line | HT-29 | Homo sapiens | IC50 | = | 2750 | nM | 21435753 |
NPT367 | Cell Line | MDA-N | Homo sapiens | GI50 | 63973.48 | nM | PubChem BioAssay data set | |
NPT368 | Cell Line | SN12C | Homo sapiens | GI50 | 446.68 | nM | PubChem BioAssay data set | |
NPT369 | Cell Line | ACHN | Homo sapiens | GI50 | 71944.9 | nM | PubChem BioAssay data set | |
NPT370 | Cell Line | NCI-H23 | Homo sapiens | GI50 | 1071.52 | nM | PubChem BioAssay data set | |
NPT371 | Cell Line | UO-31 | Homo sapiens | GI50 | 61376.2 | nM | PubChem BioAssay data set | |
NPT372 | Cell Line | HOP-92 | Homo sapiens | GI50 | 2065.38 | nM | PubChem BioAssay data set | |
NPT116 | Cell Line | HL-60 | Homo sapiens | GI50 | 4246.2 | nM | PubChem BioAssay data set | |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | 2523.48 | nM | PubChem BioAssay data set | |
NPT374 | Cell Line | SF-539 | Homo sapiens | GI50 | 1778.28 | nM | PubChem BioAssay data set | |
NPT375 | Cell Line | Malme-3M | Homo sapiens | GI50 | 14521.12 | nM | PubChem BioAssay data set | |
NPT373 | Cell Line | SK-MEL-5 | Homo sapiens | GI50 | 5272.3 | nM | PubChem BioAssay data set | |
NPT376 | Cell Line | A498 | Homo sapiens | GI50 | 1091.44 | nM | PubChem BioAssay data set | |
NPT111 | Cell Line | K562 | Homo sapiens | GI50 | 4508.17 | nM | PubChem BioAssay data set | |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | GI50 | 2238.72 | nM | PubChem BioAssay data set | |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | GI50 | 411.15 | nM | PubChem BioAssay data set | |
NPT379 | Cell Line | HOP-62 | Homo sapiens | GI50 | 2177.71 | nM | PubChem BioAssay data set | |
NPT378 | Cell Line | NCI/ADR-RES | Homo sapiens | GI50 | 26977.39 | nM | PubChem BioAssay data set | |
NPT380 | Cell Line | U-251 | Homo sapiens | GI50 | 370.68 | nM | PubChem BioAssay data set | |
NPT382 | Cell Line | OVCAR-5 | Homo sapiens | GI50 | 1241.65 | nM | PubChem BioAssay data set | |
NPT381 | Cell Line | OVCAR-8 | Homo sapiens | GI50 | 1807.17 | nM | PubChem BioAssay data set | |
NPT572 | Cell Line | DMS-273 | Homo sapiens | GI50 | 744.73 | nM | PubChem BioAssay data set | |
NPT383 | Cell Line | SNB-19 | Homo sapiens | GI50 | 698.23 | nM | PubChem BioAssay data set | |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | GI50 | 2624.22 | nM | PubChem BioAssay data set | |
NPT384 | Cell Line | TK-10 | Homo sapiens | GI50 | 29308.93 | nM | PubChem BioAssay data set | |
NPT385 | Cell Line | SR | Homo sapiens | GI50 | 839.46 | nM | PubChem BioAssay data set | |
NPT573 | Cell Line | M19-MEL | Homo sapiens | GI50 | 1270.57 | nM | PubChem BioAssay data set | |
NPT323 | Cell Line | SW-620 | Homo sapiens | GI50 | 1135.01 | nM | PubChem BioAssay data set | |
NPT455 | Cell Line | NCI-H522 | Homo sapiens | GI50 | 240.44 | nM | PubChem BioAssay data set | |
NPT386 | Cell Line | KM12 | Homo sapiens | GI50 | 2070.14 | nM | PubChem BioAssay data set | |
NPT574 | Cell Line | XF498 | Homo sapiens | GI50 | 2660.73 | nM | PubChem BioAssay data set | |
NPT387 | Cell Line | M14 | Homo sapiens | GI50 | 17060.82 | nM | PubChem BioAssay data set | |
NPT388 | Cell Line | NCI-H322M | Homo sapiens | GI50 | 3515.6 | nM | PubChem BioAssay data set | |
NPT389 | Cell Line | RPMI-8226 | Homo sapiens | GI50 | 2060.63 | nM | PubChem BioAssay data set | |
NPT390 | Cell Line | LOX IMVI | Homo sapiens | GI50 | 3971.92 | nM | PubChem BioAssay data set | |
NPT456 | Cell Line | OVCAR-4 | Homo sapiens | GI50 | 3451.44 | nM | PubChem BioAssay data set | |
NPT457 | Cell Line | BT-549 | Homo sapiens | GI50 | 6501.3 | nM | PubChem BioAssay data set | |
NPT575 | Cell Line | KM-20L2 | Homo sapiens | GI50 | 608.14 | nM | PubChem BioAssay data set | |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | GI50 | 2679.17 | nM | PubChem BioAssay data set | |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | 180.3 | nM | PubChem BioAssay data set | |
NPT391 | Cell Line | HCC 2998 | Homo sapiens | GI50 | 2070.14 | nM | PubChem BioAssay data set | |
NPT392 | Cell Line | SNB-75 | Homo sapiens | GI50 | 219.79 | nM | PubChem BioAssay data set | |
NPT148 | Cell Line | HCT-15 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI50 | 5956.62 | nM | PubChem BioAssay data set | |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | 126.18 | nM | PubChem BioAssay data set | |
NPT306 | Cell Line | PC-3 | Homo sapiens | GI50 | 2333.46 | nM | PubChem BioAssay data set | |
NPT394 | Cell Line | EKVX | Homo sapiens | GI50 | 1698.24 | nM | PubChem BioAssay data set | |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI50 | 1135.01 | nM | PubChem BioAssay data set | |
NPT146 | Cell Line | SK-OV-3 | Homo sapiens | GI50 | 877 | nM | PubChem BioAssay data set | |
NPT731 | Cell Line | LXFL 529 | Homo sapiens | GI50 | 1399.59 | nM | PubChem BioAssay data set | |
NPT576 | Cell Line | DMS-114 | Homo sapiens | GI50 | 1238.8 | nM | PubChem BioAssay data set | |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | 1733.8 | nM | PubChem BioAssay data set | |
NPT398 | Cell Line | UACC-62 | Homo sapiens | GI50 | 1247.38 | nM | PubChem BioAssay data set | |
NPT308 | Cell Line | CAKI-1 | Homo sapiens | GI50 | 2371.37 | nM | PubChem BioAssay data set | |
NPT400 | Cell Line | MDA-MB-435 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT399 | Cell Line | SF-295 | Homo sapiens | GI50 | 5929.25 | nM | PubChem BioAssay data set | |
NPT458 | Cell Line | IGROV-1 | Homo sapiens | GI50 | 1030.39 | nM | PubChem BioAssay data set | |
NPT401 | Cell Line | 786-0 | Homo sapiens | GI50 | 2488.86 | nM | PubChem BioAssay data set | |
NPT577 | Cell Line | RXF 631 | Homo sapiens | GI50 | 19769.7 | nM | PubChem BioAssay data set | |
NPT402 | Cell Line | Hs-578T | Homo sapiens | GI50 | 2904.02 | nM | PubChem BioAssay data set | |
NPT403 | Cell Line | UACC-257 | Homo sapiens | GI50 | 26121.61 | nM | PubChem BioAssay data set | |
NPT578 | Cell Line | SNB-78 | Homo sapiens | GI50 | 3372.87 | nM | PubChem BioAssay data set | |
NPT579 | Cell Line | DLD-1 | Homo sapiens | GI50 | 14859.36 | nM | PubChem BioAssay data set | |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | GI50 | 751.62 | nM | PubChem BioAssay data set | |
NPT405 | Cell Line | NCI-H226 | Homo sapiens | GI50 | 3605.79 | nM | PubChem BioAssay data set | |
NPT139 | Cell Line | HT-29 | Homo sapiens | GI50 | 1563.15 | nM | PubChem BioAssay data set | |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | GI50 | 9375.62 | nM | PubChem BioAssay data set | |
NPT406 | Cell Line | RXF 393 | Homo sapiens | GI50 | 12387.97 | nM | PubChem BioAssay data set | |
NPT407 | Cell Line | COLO 205 | Homo sapiens | GI50 | 1659.59 | nM | PubChem BioAssay data set | |
NPT732 | Cell Line | HOP-18 | Homo sapiens | GI50 | 19498.45 | nM | PubChem BioAssay data set | |
NPT393 | Cell Line | HCT-116 | Homo sapiens | IC50 | = | 4420 | nM | 26026362 |
NPT65 | Cell Line | HepG2 | Homo sapiens | IC50 | = | 3520 | nM | 26026362 |
NPT116 | Cell Line | HL-60 | Homo sapiens | IC50 | = | 3410 | nM | 26026362 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC149471 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC271215 |
0.9841 | High Similarity | NPC188420 |
0.9793 | High Similarity | NPC100079 |
0.9793 | High Similarity | NPC23614 |
0.9641 | High Similarity | NPC46451 |
0.9637 | High Similarity | NPC235076 |
0.949 | High Similarity | NPC204446 |
0.93 | High Similarity | NPC118121 |
0.9175 | High Similarity | NPC313189 |
0.9137 | High Similarity | NPC251160 |
0.9062 | High Similarity | NPC477019 |
0.9062 | High Similarity | NPC234197 |
0.904 | High Similarity | NPC202768 |
0.904 | High Similarity | NPC296482 |
0.904 | High Similarity | NPC53069 |
0.898 | High Similarity | NPC135549 |
0.885 | High Similarity | NPC96405 |
0.885 | High Similarity | NPC171409 |
0.8821 | High Similarity | NPC31930 |
0.8814 | High Similarity | NPC4071 |
0.8814 | High Similarity | NPC476582 |
0.8814 | High Similarity | NPC476578 |
0.8698 | High Similarity | NPC195268 |
0.8698 | High Similarity | NPC133140 |
0.8687 | High Similarity | NPC36229 |
0.8687 | High Similarity | NPC476581 |
0.8687 | High Similarity | NPC16452 |
0.8473 | Intermediate Similarity | NPC290689 |
0.8466 | Intermediate Similarity | NPC287588 |
0.839 | Intermediate Similarity | NPC202605 |
0.839 | Intermediate Similarity | NPC112206 |
0.8372 | Intermediate Similarity | NPC22481 |
0.8333 | Intermediate Similarity | NPC179704 |
0.8318 | Intermediate Similarity | NPC278525 |
0.8295 | Intermediate Similarity | NPC108342 |
0.8257 | Intermediate Similarity | NPC182907 |
0.8257 | Intermediate Similarity | NPC189903 |
0.8252 | Intermediate Similarity | NPC208284 |
0.8249 | Intermediate Similarity | NPC253675 |
0.8247 | Intermediate Similarity | NPC204385 |
0.8229 | Intermediate Similarity | NPC206201 |
0.8219 | Intermediate Similarity | NPC166722 |
0.8208 | Intermediate Similarity | NPC122463 |
0.8113 | Intermediate Similarity | NPC174049 |
0.8103 | Intermediate Similarity | NPC249405 |
0.8063 | Intermediate Similarity | NPC210296 |
0.8037 | Intermediate Similarity | NPC210434 |
0.8036 | Intermediate Similarity | NPC124313 |
0.803 | Intermediate Similarity | NPC474904 |
0.803 | Intermediate Similarity | NPC312531 |
0.8029 | Intermediate Similarity | NPC470020 |
0.8027 | Intermediate Similarity | NPC84164 |
0.8027 | Intermediate Similarity | NPC207283 |
0.8 | Intermediate Similarity | NPC302001 |
0.7982 | Intermediate Similarity | NPC24019 |
0.7969 | Intermediate Similarity | NPC312872 |
0.7915 | Intermediate Similarity | NPC236668 |
0.7915 | Intermediate Similarity | NPC266931 |
0.7887 | Intermediate Similarity | NPC473513 |
0.7883 | Intermediate Similarity | NPC295228 |
0.7877 | Intermediate Similarity | NPC146976 |
0.786 | Intermediate Similarity | NPC183537 |
0.7843 | Intermediate Similarity | NPC23080 |
0.7843 | Intermediate Similarity | NPC193906 |
0.7833 | Intermediate Similarity | NPC162653 |
0.783 | Intermediate Similarity | NPC162530 |
0.7805 | Intermediate Similarity | NPC212163 |
0.7805 | Intermediate Similarity | NPC287437 |
0.7795 | Intermediate Similarity | NPC285941 |
0.7793 | Intermediate Similarity | NPC96584 |
0.7793 | Intermediate Similarity | NPC255800 |
0.7788 | Intermediate Similarity | NPC285558 |
0.7783 | Intermediate Similarity | NPC77878 |
0.7773 | Intermediate Similarity | NPC270515 |
0.7767 | Intermediate Similarity | NPC173080 |
0.7758 | Intermediate Similarity | NPC90875 |
0.7749 | Intermediate Similarity | NPC24954 |
0.7748 | Intermediate Similarity | NPC233334 |
0.7743 | Intermediate Similarity | NPC217554 |
0.7729 | Intermediate Similarity | NPC295676 |
0.7719 | Intermediate Similarity | NPC284141 |
0.7703 | Intermediate Similarity | NPC476999 |
0.7703 | Intermediate Similarity | NPC201508 |
0.7692 | Intermediate Similarity | NPC476997 |
0.7685 | Intermediate Similarity | NPC473822 |
0.7682 | Intermediate Similarity | NPC470018 |
0.7677 | Intermediate Similarity | NPC190461 |
0.7667 | Intermediate Similarity | NPC304183 |
0.7667 | Intermediate Similarity | NPC323345 |
0.7667 | Intermediate Similarity | NPC470164 |
0.7658 | Intermediate Similarity | NPC476996 |
0.7658 | Intermediate Similarity | NPC476998 |
0.7656 | Intermediate Similarity | NPC475774 |
0.7655 | Intermediate Similarity | NPC11408 |
0.7647 | Intermediate Similarity | NPC74575 |
0.7626 | Intermediate Similarity | NPC280272 |
0.7619 | Intermediate Similarity | NPC244606 |
0.7619 | Intermediate Similarity | NPC156728 |
0.7613 | Intermediate Similarity | NPC476994 |
0.7602 | Intermediate Similarity | NPC214980 |
0.7598 | Intermediate Similarity | NPC114335 |
0.7598 | Intermediate Similarity | NPC280964 |
0.7598 | Intermediate Similarity | NPC141915 |
0.7594 | Intermediate Similarity | NPC82548 |
0.7589 | Intermediate Similarity | NPC49547 |
0.7569 | Intermediate Similarity | NPC148409 |
0.7549 | Intermediate Similarity | NPC92111 |
0.7535 | Intermediate Similarity | NPC316981 |
0.7525 | Intermediate Similarity | NPC33902 |
0.7525 | Intermediate Similarity | NPC276674 |
0.7523 | Intermediate Similarity | NPC123976 |
0.7523 | Intermediate Similarity | NPC11464 |
0.7523 | Intermediate Similarity | NPC167860 |
0.7522 | Intermediate Similarity | NPC15406 |
0.7513 | Intermediate Similarity | NPC477559 |
0.7513 | Intermediate Similarity | NPC232924 |
0.7513 | Intermediate Similarity | NPC160298 |
0.7513 | Intermediate Similarity | NPC306902 |
0.7513 | Intermediate Similarity | NPC266753 |
0.7512 | Intermediate Similarity | NPC176538 |
0.7512 | Intermediate Similarity | NPC11017 |
0.75 | Intermediate Similarity | NPC76748 |
0.7489 | Intermediate Similarity | NPC470017 |
0.7477 | Intermediate Similarity | NPC174758 |
0.7476 | Intermediate Similarity | NPC307963 |
0.7465 | Intermediate Similarity | NPC474595 |
0.7458 | Intermediate Similarity | NPC132385 |
0.7456 | Intermediate Similarity | NPC470022 |
0.7456 | Intermediate Similarity | NPC476995 |
0.7454 | Intermediate Similarity | NPC94157 |
0.7451 | Intermediate Similarity | NPC320088 |
0.7451 | Intermediate Similarity | NPC296527 |
0.7449 | Intermediate Similarity | NPC476432 |
0.7449 | Intermediate Similarity | NPC24264 |
0.7444 | Intermediate Similarity | NPC200888 |
0.7431 | Intermediate Similarity | NPC170114 |
0.743 | Intermediate Similarity | NPC470931 |
0.7414 | Intermediate Similarity | NPC208522 |
0.7411 | Intermediate Similarity | NPC247389 |
0.7409 | Intermediate Similarity | NPC193267 |
0.7409 | Intermediate Similarity | NPC213530 |
0.7404 | Intermediate Similarity | NPC251090 |
0.7401 | Intermediate Similarity | NPC470889 |
0.7398 | Intermediate Similarity | NPC302527 |
0.7398 | Intermediate Similarity | NPC225774 |
0.7398 | Intermediate Similarity | NPC167546 |
0.7398 | Intermediate Similarity | NPC16805 |
0.7393 | Intermediate Similarity | NPC232727 |
0.7385 | Intermediate Similarity | NPC470549 |
0.738 | Intermediate Similarity | NPC473183 |
0.7371 | Intermediate Similarity | NPC329708 |
0.7371 | Intermediate Similarity | NPC165349 |
0.7371 | Intermediate Similarity | NPC264166 |
0.7371 | Intermediate Similarity | NPC274291 |
0.7371 | Intermediate Similarity | NPC47059 |
0.7371 | Intermediate Similarity | NPC118832 |
0.7368 | Intermediate Similarity | NPC224928 |
0.7361 | Intermediate Similarity | NPC199667 |
0.736 | Intermediate Similarity | NPC219341 |
0.7359 | Intermediate Similarity | NPC99891 |
0.7346 | Intermediate Similarity | NPC315957 |
0.7336 | Intermediate Similarity | NPC472111 |
0.733 | Intermediate Similarity | NPC296742 |
0.7323 | Intermediate Similarity | NPC298979 |
0.7323 | Intermediate Similarity | NPC210918 |
0.7315 | Intermediate Similarity | NPC473181 |
0.7315 | Intermediate Similarity | NPC201697 |
0.7315 | Intermediate Similarity | NPC174672 |
0.7308 | Intermediate Similarity | NPC78284 |
0.7306 | Intermediate Similarity | NPC76079 |
0.7302 | Intermediate Similarity | NPC193777 |
0.7294 | Intermediate Similarity | NPC26679 |
0.7294 | Intermediate Similarity | NPC473180 |
0.7293 | Intermediate Similarity | NPC473184 |
0.729 | Intermediate Similarity | NPC137929 |
0.729 | Intermediate Similarity | NPC164374 |
0.7286 | Intermediate Similarity | NPC241055 |
0.7282 | Intermediate Similarity | NPC224293 |
0.7277 | Intermediate Similarity | NPC135887 |
0.7277 | Intermediate Similarity | NPC199277 |
0.7277 | Intermediate Similarity | NPC322482 |
0.7273 | Intermediate Similarity | NPC86144 |
0.7273 | Intermediate Similarity | NPC304659 |
0.7273 | Intermediate Similarity | NPC274982 |
0.7264 | Intermediate Similarity | NPC329747 |
0.7264 | Intermediate Similarity | NPC329793 |
0.7263 | Intermediate Similarity | NPC475959 |
0.726 | Intermediate Similarity | NPC478074 |
0.7256 | Intermediate Similarity | NPC474145 |
0.7256 | Intermediate Similarity | NPC475841 |
0.7252 | Intermediate Similarity | NPC17565 |
0.7251 | Intermediate Similarity | NPC17677 |
0.7249 | Intermediate Similarity | NPC473182 |
0.7246 | Intermediate Similarity | NPC112676 |
0.7243 | Intermediate Similarity | NPC223427 |
0.7243 | Intermediate Similarity | NPC245816 |
0.7243 | Intermediate Similarity | NPC476138 |
0.724 | Intermediate Similarity | NPC476568 |
0.7238 | Intermediate Similarity | NPC473053 |
0.7235 | Intermediate Similarity | NPC185782 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC149471 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9641 | High Similarity | NPD3763 | Approved |
0.904 | High Similarity | NPD3816 | Phase 1 |
0.904 | High Similarity | NPD3815 | Phase 1 |
0.8698 | High Similarity | NPD3923 | Approved |
0.8698 | High Similarity | NPD3921 | Approved |
0.8698 | High Similarity | NPD3924 | Approved |
0.8698 | High Similarity | NPD3922 | Approved |
0.8125 | Intermediate Similarity | NPD3920 | Phase 2 |
0.8037 | Intermediate Similarity | NPD6494 | Phase 2 |
0.7847 | Intermediate Similarity | NPD5658 | Approved |
0.7839 | Intermediate Similarity | NPD6257 | Clinical (unspecified phase) |
0.7799 | Intermediate Similarity | NPD7222 | Phase 2 |
0.7783 | Intermediate Similarity | NPD4418 | Discontinued |
0.7766 | Intermediate Similarity | NPD7414 | Clinical (unspecified phase) |
0.7761 | Intermediate Similarity | NPD6281 | Approved |
0.7668 | Intermediate Similarity | NPD4885 | Approved |
0.7658 | Intermediate Similarity | NPD7567 | Approved |
0.7642 | Intermediate Similarity | NPD6230 | Discontinued |
0.7639 | Intermediate Similarity | NPD4926 | Clinical (unspecified phase) |
0.7583 | Intermediate Similarity | NPD5530 | Phase 1 |
0.7581 | Intermediate Similarity | NPD7571 | Clinical (unspecified phase) |
0.7562 | Intermediate Similarity | NPD4889 | Approved |
0.7547 | Intermediate Similarity | NPD7453 | Approved |
0.7547 | Intermediate Similarity | NPD7452 | Approved |
0.7536 | Intermediate Similarity | NPD4795 | Phase 2 |
0.7535 | Intermediate Similarity | NPD7069 | Discontinued |
0.7534 | Intermediate Similarity | NPD7555 | Discontinued |
0.7524 | Intermediate Similarity | NPD6975 | Discontinued |
0.7522 | Intermediate Similarity | NPD6963 | Approved |
0.7522 | Intermediate Similarity | NPD6964 | Approved |
0.7476 | Intermediate Similarity | NPD1304 | Clinical (unspecified phase) |
0.7476 | Intermediate Similarity | NPD1038 | Approved |
0.7455 | Intermediate Similarity | NPD5070 | Clinical (unspecified phase) |
0.7431 | Intermediate Similarity | NPD5612 | Discontinued |
0.7429 | Intermediate Similarity | NPD6219 | Discontinued |
0.7427 | Intermediate Similarity | NPD6569 | Phase 2 |
0.7424 | Intermediate Similarity | NPD1923 | Clinical (unspecified phase) |
0.7411 | Intermediate Similarity | NPD1078 | Clinical (unspecified phase) |
0.7399 | Intermediate Similarity | NPD7719 | Discontinued |
0.7385 | Intermediate Similarity | NPD6140 | Clinical (unspecified phase) |
0.7383 | Intermediate Similarity | NPD5429 | Discontinued |
0.7381 | Intermediate Similarity | NPD4118 | Clinical (unspecified phase) |
0.7378 | Intermediate Similarity | NPD7710 | Clinical (unspecified phase) |
0.7371 | Intermediate Similarity | NPD4036 | Approved |
0.7371 | Intermediate Similarity | NPD4037 | Approved |
0.7371 | Intermediate Similarity | NPD4039 | Approved |
0.7371 | Intermediate Similarity | NPD4033 | Approved |
0.7371 | Intermediate Similarity | NPD31 | Approved |
0.7371 | Intermediate Similarity | NPD4034 | Approved |
0.7371 | Intermediate Similarity | NPD32 | Approved |
0.7371 | Intermediate Similarity | NPD4122 | Approved |
0.7371 | Intermediate Similarity | NPD4035 | Approved |
0.7371 | Intermediate Similarity | NPD4038 | Approved |
0.7358 | Intermediate Similarity | NPD6477 | Clinical (unspecified phase) |
0.7348 | Intermediate Similarity | NPD7729 | Clinical (unspecified phase) |
0.7346 | Intermediate Similarity | NPD1739 | Approved |
0.7346 | Intermediate Similarity | NPD1740 | Approved |
0.7345 | Intermediate Similarity | NPD5801 | Clinical (unspecified phase) |
0.7325 | Intermediate Similarity | NPD7558 | Phase 2 |
0.7322 | Intermediate Similarity | NPD8091 | Phase 3 |
0.7321 | Intermediate Similarity | NPD3477 | Phase 2 |
0.7321 | Intermediate Similarity | NPD3478 | Clinical (unspecified phase) |
0.7316 | Intermediate Similarity | NPD8017 | Clinical (unspecified phase) |
0.7316 | Intermediate Similarity | NPD8016 | Phase 3 |
0.7304 | Intermediate Similarity | NPD7424 | Clinical (unspecified phase) |
0.7297 | Intermediate Similarity | NPD7678 | Clinical (unspecified phase) |
0.729 | Intermediate Similarity | NPD3397 | Phase 2 |
0.7269 | Intermediate Similarity | NPD5863 | Clinical (unspecified phase) |
0.7256 | Intermediate Similarity | NPD2060 | Approved |
0.725 | Intermediate Similarity | NPD7169 | Suspended |
0.7248 | Intermediate Similarity | NPD4502 | Phase 2 |
0.7234 | Intermediate Similarity | NPD8100 | Phase 3 |
0.7227 | Intermediate Similarity | NPD5903 | Approved |
0.7227 | Intermediate Similarity | NPD5902 | Approved |
0.7222 | Intermediate Similarity | NPD6872 | Clinical (unspecified phase) |
0.722 | Intermediate Similarity | NPD5930 | Phase 3 |
0.722 | Intermediate Similarity | NPD6344 | Clinical (unspecified phase) |
0.7217 | Intermediate Similarity | NPD3825 | Phase 3 |
0.7212 | Intermediate Similarity | NPD7675 | Phase 3 |
0.7212 | Intermediate Similarity | NPD7674 | Phase 3 |
0.7212 | Intermediate Similarity | NPD7676 | Clinical (unspecified phase) |
0.7207 | Intermediate Similarity | NPD7395 | Discontinued |
0.7207 | Intermediate Similarity | NPD3354 | Phase 2 |
0.7193 | Intermediate Similarity | NPD8052 | Clinical (unspecified phase) |
0.719 | Intermediate Similarity | NPD6491 | Clinical (unspecified phase) |
0.719 | Intermediate Similarity | NPD6861 | Clinical (unspecified phase) |
0.7189 | Intermediate Similarity | NPD7671 | Approved |
0.7189 | Intermediate Similarity | NPD4859 | Phase 1 |
0.7189 | Intermediate Similarity | NPD7672 | Approved |
0.7179 | Intermediate Similarity | NPD4875 | Phase 3 |
0.7179 | Intermediate Similarity | NPD6517 | Phase 3 |
0.7179 | Intermediate Similarity | NPD4876 | Phase 3 |
0.7155 | Intermediate Similarity | NPD7859 | Phase 2 |
0.7143 | Intermediate Similarity | NPD6242 | Discontinued |
0.7143 | Intermediate Similarity | NPD8101 | Phase 3 |
0.7143 | Intermediate Similarity | NPD4551 | Phase 2 |
0.7129 | Intermediate Similarity | NPD6375 | Clinical (unspecified phase) |
0.7123 | Intermediate Similarity | NPD7948 | Phase 1 |
0.7122 | Intermediate Similarity | NPD5522 | Clinical (unspecified phase) |
0.7121 | Intermediate Similarity | NPD2782 | Approved |
0.7121 | Intermediate Similarity | NPD2780 | Approved |
0.7113 | Intermediate Similarity | NPD6503 | Clinical (unspecified phase) |
0.7111 | Intermediate Similarity | NPD4881 | Clinical (unspecified phase) |
0.7105 | Intermediate Similarity | NPD6553 | Clinical (unspecified phase) |
0.71 | Intermediate Similarity | NPD5040 | Clinical (unspecified phase) |
0.71 | Intermediate Similarity | NPD6741 | Clinical (unspecified phase) |
0.7097 | Intermediate Similarity | NPD5601 | Phase 2 |
0.7087 | Intermediate Similarity | NPD4995 | Approved |
0.7087 | Intermediate Similarity | NPD4996 | Approved |
0.708 | Intermediate Similarity | NPD1856 | Discontinued |
0.7079 | Intermediate Similarity | NPD5602 | Clinical (unspecified phase) |
0.7073 | Intermediate Similarity | NPD4203 | Approved |
0.7073 | Intermediate Similarity | NPD4204 | Approved |
0.7073 | Intermediate Similarity | NPD3386 | Phase 2 |
0.7064 | Intermediate Similarity | NPD6790 | Phase 1 |
0.7062 | Intermediate Similarity | NPD5575 | Clinical (unspecified phase) |
0.7061 | Intermediate Similarity | NPD7426 | Phase 1 |
0.7054 | Intermediate Similarity | NPD6568 | Discontinued |
0.7054 | Intermediate Similarity | NPD8109 | Clinical (unspecified phase) |
0.705 | Intermediate Similarity | NPD2781 | Approved |
0.7048 | Intermediate Similarity | NPD2334 | Discontinued |
0.7043 | Intermediate Similarity | NPD4925 | Approved |
0.7043 | Intermediate Similarity | NPD6968 | Phase 2 |
0.7043 | Intermediate Similarity | NPD6969 | Phase 2 |
0.7034 | Intermediate Similarity | NPD6716 | Phase 1 |
0.7032 | Intermediate Similarity | NPD2189 | Approved |
0.7032 | Intermediate Similarity | NPD2739 | Clinical (unspecified phase) |
0.7032 | Intermediate Similarity | NPD5528 | Clinical (unspecified phase) |
0.7032 | Intermediate Similarity | NPD2187 | Approved |
0.7032 | Intermediate Similarity | NPD5529 | Phase 1 |
0.7017 | Intermediate Similarity | NPD5488 | Discontinued |
0.7014 | Intermediate Similarity | NPD5939 | Approved |
0.7014 | Intermediate Similarity | NPD5936 | Approved |
0.7009 | Intermediate Similarity | NPD7889 | Clinical (unspecified phase) |
0.7009 | Intermediate Similarity | NPD7823 | Clinical (unspecified phase) |
0.7005 | Intermediate Similarity | NPD6991 | Approved |
0.7005 | Intermediate Similarity | NPD5083 | Clinical (unspecified phase) |
0.7004 | Intermediate Similarity | NPD1954 | Phase 1 |
0.7 | Intermediate Similarity | NPD2125 | Clinical (unspecified phase) |
0.7 | Intermediate Similarity | NPD5559 | Phase 2 |
0.6995 | Remote Similarity | NPD6550 | Discontinued |
0.698 | Remote Similarity | NPD5934 | Clinical (unspecified phase) |
0.6977 | Remote Similarity | NPD4548 | Discontinued |
0.6964 | Remote Similarity | NPD6147 | Clinical (unspecified phase) |
0.6964 | Remote Similarity | NPD7112 | Discontinued |
0.6963 | Remote Similarity | NPD6769 | Clinical (unspecified phase) |
0.696 | Remote Similarity | NPD6298 | Discontinued |
0.6949 | Remote Similarity | NPD5905 | Phase 1 |
0.6948 | Remote Similarity | NPD3324 | Clinical (unspecified phase) |
0.6947 | Remote Similarity | NPD6500 | Approved |
0.6947 | Remote Similarity | NPD6501 | Approved |
0.6944 | Remote Similarity | NPD4396 | Clinical (unspecified phase) |
0.6941 | Remote Similarity | NPD6150 | Discontinued |
0.6939 | Remote Similarity | NPD7955 | Approved |
0.6939 | Remote Similarity | NPD7956 | Approved |
0.6938 | Remote Similarity | NPD4375 | Approved |
0.6937 | Remote Similarity | NPD4131 | Phase 3 |
0.6937 | Remote Similarity | NPD5066 | Phase 2 |
0.6937 | Remote Similarity | NPD5067 | Phase 2 |
0.6936 | Remote Similarity | NPD5805 | Approved |
0.6933 | Remote Similarity | NPD5164 | Discontinued |
0.6929 | Remote Similarity | NPD6244 | Phase 3 |
0.6929 | Remote Similarity | NPD6243 | Phase 3 |
0.6927 | Remote Similarity | NPD5751 | Clinical (unspecified phase) |
0.6923 | Remote Similarity | NPD5917 | Clinical (unspecified phase) |
0.692 | Remote Similarity | NPD7417 | Discontinued |
0.6915 | Remote Similarity | NPD7201 | Clinical (unspecified phase) |
0.6913 | Remote Similarity | NPD7050 | Clinical (unspecified phase) |
0.6913 | Remote Similarity | NPD7051 | Phase 3 |
0.6911 | Remote Similarity | NPD6228 | Discontinued |
0.6911 | Remote Similarity | NPD7708 | Approved |
0.6909 | Remote Similarity | NPD1392 | Approved |
0.6907 | Remote Similarity | NPD6727 | Phase 2 |
0.6904 | Remote Similarity | NPD5483 | Clinical (unspecified phase) |
0.6903 | Remote Similarity | NPD4429 | Discontinued |
0.6898 | Remote Similarity | NPD6661 | Clinical (unspecified phase) |
0.6895 | Remote Similarity | NPD4664 | Clinical (unspecified phase) |
0.6892 | Remote Similarity | NPD6262 | Clinical (unspecified phase) |
0.6884 | Remote Similarity | NPD112 | Approved |
0.6884 | Remote Similarity | NPD9705 | Discontinued |
0.6884 | Remote Similarity | NPD6988 | Phase 1 |
0.6878 | Remote Similarity | NPD7025 | Clinical (unspecified phase) |
0.6878 | Remote Similarity | NPD5100 | Phase 3 |
0.6875 | Remote Similarity | NPD5945 | Phase 1 |
0.6875 | Remote Similarity | NPD5944 | Phase 1 |
0.6872 | Remote Similarity | NPD3402 | Phase 1 |
0.6872 | Remote Similarity | NPD7194 | Discontinued |
0.6869 | Remote Similarity | NPD6590 | Discontinued |
0.6869 | Remote Similarity | NPD3396 | Approved |
0.6869 | Remote Similarity | NPD3395 | Approved |
0.6864 | Remote Similarity | NPD3003 | Approved |
0.6863 | Remote Similarity | NPD6607 | Clinical (unspecified phase) |
0.6857 | Remote Similarity | NPD4919 | Phase 3 |
0.6857 | Remote Similarity | NPD4921 | Phase 3 |
0.6857 | Remote Similarity | NPD2917 | Approved |
0.6857 | Remote Similarity | NPD4920 | Clinical (unspecified phase) |
0.6847 | Remote Similarity | NPD4437 | Phase 3 |
0.6846 | Remote Similarity | NPD8358 | Approved |
0.6845 | Remote Similarity | NPD1032 | Phase 2 |
0.684 | Remote Similarity | NPD8063 | Discontinued |
PubChem CID   | 25659 |
ChEMBL   | CHEMBL8443 |
ZINC   |
Molecular Weight:   | 348.12 |
ALogP:   | -1.7479 |
MLogP:   | 3.22 |
XLogP:   | 3.37 |
# Rotatable Bonds:   | 5 |
Polar Surface Area:   | 40.8 |
# H-Bond Aceptor:   | 0 |
# H-Bond Donor:   | 0 |
# Rings:   | 5 |
# Heavy Atoms:   | 26 |